NIFTY 50

After whistleblower complaint, Sun Pharmaceutical to restructure Aditya Medisales

Updated : January 21, 2019 02:40 PM IST

After a news report that a whistleblower complaint raised concerns on the drugmaker’s corporate governance, Sun Pharmaceutical Industries, said it's planning to restructure Aditya Medisales Ltd and will provide clarity on advances to third party loans, sources privy to the developments told CNBC-TV18.

The whistleblower alleged financial irregularities and related party transactions with Aditya Medisales Ltd, a privately-held distributor company for Sun Pharma.

Surajit Pal, equity research analyst, Prabhudas Lilladher, said, "This will help to reassure the investors, but it all depends on the quality of information to be shared. We don’t know exactly what are the kind of third party sales."
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV